Resonance Health announced that it has appointed Mr. Mitchell Wells as a Non-Executive Director of the company. Wells replaces Dr. Jason Loveridge who resigned as a Non-Executive Director of the company on 30 June 2017 to take up a senior position at a pharmaceutical company. Since May 2017 Mr. Wells has provided corporate, legal and investor-relations consulting services to the company and he will continue to consult to the company for one to two days per week, or as required by the company.